BARDA is contributing funding for a Phase 3 clinical test of a Moderna messenger RNA vaccine that could protect against the strains of bird flu virus now spreading in U.S. dairy cows. The Moderna ...

The FDA's decision breaks sharply from previous policy, which recommended annual COVID-19 shots for nearly everyone 6 months ...

Moderna revealed Wednesday that its flu vaccine using mRNA technology has offered promising results as the flu season begins to ramp up. Moderna announced that its seasonal flu vaccine “demons… ...

Moderna Inc. on Tuesday reported "positive interim results" from a late-stage trial of what it calls the "next-generation COVID-19 vaccine." ...

This year it will also serve as the first big test of demand for COVID shots. COVID vaccine makers Pfizer, Moderna, and Novavax have been working on updated vaccines that target new variants.

Moderna is eyeing testing two vaccine candidates, one for mpox and another for bird flu, in humans later this year.

The drug company’s latest vaccine, built from the same mRNA technology that created the Covid-19 vaccine, was found to significantly reduce risk of relapse or death from melanoma.

Moderna this week said preliminary clinical trial data confirmed that its updated COVID-19 vaccine provides a “significant boost” in neutralizing antibodies against emerging SARS-CoV-2 ...

Vaccine makers Pfizer and Moderna are trying to get out ahead of some of the new coronavirus variants that are causing concern around the world.

Vaccine manufacturer Moderna is to test out a jab against the South African variant of the virus that causes COVID-19. The company made the decision after laboratory tests showed a six-fold ...

Roche is partnering with Moderna to include a COVID-19 antibody test in the mRNA specialist's ongoing vaccine trials, the Swiss drugmaker said on Wednesday, potentially demonstrating if the ...